相关实验视频
Updated: May 16, 2025

09:51
Cochlear Surface Preparation in the Adult Mouse
Published on: November 6, 2019
15.6K
TNFAIP8L2维持毛细胞功能,并通过mTORC1信号传递调节与年龄相关的听力损失
1School of Clinical and Basic Medical Sciences, Shandong Provincial Hospital, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
概括
瘤缩因子-α诱导蛋白-8-like 2 (TNFAIP8L2) 缺乏症通过激活mTORC1信号,导致与年龄相关的听力损失. 用拉巴胺素抑制这种途径或准RHEB/RAC1显示出对听力退化有治疗潜力.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 与年龄相关的听力损失 (ARHL) 是一种与耳神经传感表皮损伤相关的普遍疾病.
- 拉巴amycin复合体1 (mTORC1) 信号的异常哺乳动物点有助于ARHL中的听觉毛细胞 (HC) 损失.
- 在ARHL中驱动mTORC1激活的精确机制在很大程度上是未知的.
研究的目的:
- 在ARHL中研究瘤缩因子-α诱导蛋白8-like 2 (TNFAIP8L2) 的作用.
- 为了确定TNFAIP8L2如何影响mTORC1信号传递和听觉功能.
- 探索针对TNFAIP8L2介导途径的潜在治疗策略.
主要方法:
- 产生并分析了Tnfaip8l2缺乏 (Tnfaip8l2-/-) 的小鼠.
- 评估了耳毛细胞完整性,氧化应激标志物和听觉功能.
- 服用拉巴胺素 (mTORC1抑制剂) 和在大脑中丰富的Ras同类物 (RHEB) 和与Ras相关的C3肉毒素基质1 (RAC1) 的特定抑制剂.
主要成果:
- 在耳HC中,Tnfaip8l2缺乏引起的氧化应激和与年龄相关的听力退化.
- 拉巴胺治疗显著改善了Tnfaip8l2-/-小鼠的听力功能障碍.
- 发现TNFAIP8L2通过抑制RHEB和RAC1GTPase活性来调节mTORC1;它们的抑制剂也改善了缺陷小鼠的听力.
结论:
- TNFAIP8L2在预防与年龄相关的听力退化方面发挥着至关重要的作用.
- TNFAIP8L2通过抑制RHEB和RAC1而起作用,从而调节mTORC1的信号传输.
- 针对TNFAIP8L2或其下游效应器为ARHL提供了一个有前途的治疗途径.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Hearing
51.4K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.4K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Notch Signaling Pathway
4.1K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.1K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K

